Washington, DC – According to filings with the U.S. Securities and Exchange Commission, 54Gene is raising $37,509,818.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Abasi Ene-Obong played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About 54Gene
54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market; Nearly 90% of genetic material used in pharmaceutical research is Caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.

To learn more about 54Gene, visit http://54gene.com/

Contact:
Abasi Ene-Obong, Chief Executive Officer
202-294-2955

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved